Harmonic Inc. (NASDAQ:HLIT – Get Free Report) has received an average rating of “Moderate Buy” from the six analysts that are covering the company, Marketbeat.com reports. Two equities research ...

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Harmonic ...

Needham analysts adjusted their outlook on Harmonic Inc . (NASDAQ:HLIT), lowering the price target to $14 from $18 while ...

Walter Jankovic, the Chief Financial Officer of Harmonic Inc . (NASDAQ:HLIT), recently acquired a significant number of shares in the company amid the stock's 12% decline over the past week. According ...

It's been a sad week for Harmonic Inc. ( NASDAQ:HLIT ), who've watched their investment drop 17% to US$9.51 in the ...

NEW YORK CITY, NY / ACCESS Newswire / February 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Third Harmonic Bio, Inc. (NASDAQ:THRD) revealed results from its Phase 1 single and multiple ascending dose (SAD/MAD) trial ...

Third Harmonic Bio, Inc.’s THRD share price has dipped by 30.11%, which has investors questioning if this is right time to buy.